ArticleFrontiers in oncology2024

Three-year follow-up study reveals improved survival rate in NSCLC patients underwent guideline-concordant diagnosis and treatment.

Huijuan Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.